Loading
A phase 3 trial of Geriatric assessment in Breast cancer, run by Region Örebro County, now recruiting.
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients is a phase 3 interventional study registered as NCT06044623 by Region Örebro County, with 495 participants planned, started 2024-04-01 and due to reach its primary completion in 2028-10-31. Interventions recorded: CDK 4/6 inhibitors, Endocrine therapy. Conditions recorded: Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life, Toxicity, Older Patients.
Linked to the technology Geriatric assessment because the registry's title names it ("geriatric assessment") and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Geriatric assessment and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/